The global cocaine trade operates in illicit and legal spheres, encompassing international trafficking networks and tightly-controlled commercial and pharmaceutical supply chains. The illicit market is a multi-billion-dollar enterprise driven by Andean coca cultivation and decentralized trafficking networks supplying consumer hubs. In response to widespread retail adulteration with agents such as levamisole, growing public health concerns, and risks including opioid contamination, policies increasingly emphasize harm-reduction strategies such as reagent testing kits and the distribution of reversal agents.

The legal supply chain involves strictly-regulated cultivation in countries such as Bolivia, Colombia, and Peru (where the state-run ENACO manages commercialization) with specialized industrial processing. In the United States, the Stepan Company imports and processes coca leaves to supply cocaine-free flavoring extract to The Coca-Cola Company and channels pharmaceutical-grade cocaine to Mallinckrodt for authorized medical uses such as local anesthesia.

Enforcement efforts, including coca eradication and border interdiction, have formed the backbone of the war on drugs. These strategies face ongoing criticism from experts and policymakers for causing environmental and socioeconomic damage while doing little to curb overall street availability or prices.

Leaders such as Colombian president Gustavo Petro and Amsterdam mayor Femke Halsema have advocated drug liberalization, saying that replacing prohibition with decriminalization and regulated markets is a more pragmatic and effective way to combat organized crime, reduce violence, and address public-health risks.

Illicit market The illicit market for cocaine encompasses a multi-billion-dollar global trade driven by Andean coca cultivation and decentralized, professional trafficking networks which supply consumer hubs in North America, Europe, and Oceania. Cocaine is one of the most widely-used illicit substances, characterized by widespread retail adulteration with agents such as levamisole and shifting consumption trends. Public-health and drug policies increasingly emphasize harm reduction strategies such as the distribution of reversal agents like naloxone for opioid contamination, reagent testing kits for drug-checking, and regulated safety resources.

Use and culture

Cocaine is sometimes known on the street as blow, coca, coke, bag, toot, crank, flake, snow, or soda cot. Slang terms for freebase cocaine include crack or rock.

Evidence of a link between cocaine use and violent behavior is limited; media bias and misconceptions in popular reporting may have contributed to this association, which is more likely explained by factors such as cocaine use disorder or personality disorders.

Prevalence

World annual cocaine consumption was about 600 tonnes in 2000, with the United States consuming around 50 percent of the total and Europe about 25 percent. An estimated 1.5 million people in the United States used cocaine in 2010, down from 2.4 million in 2006. European cocaine use appeared to be increasing in 2012, with the greatest use in Spain, the United Kingdom, Italy, and Ireland. The 2010 UN World Drug Report concluded that "it appears that the North American cocaine market has declined in value from US$47 billion in 1998 to US$38 billion in 2008. Between 2006 and 2008, the value of the market remained basically stable".

According to a 2016 United Nations report, England and Wales had the highest rate of cocaine usage (2.4 percent of adults in the previous year). Other countries whose use rate was 1.5 percent or more were Spain and Scotland (2.2 percent), the United States (2.1 percent), Australia (2.1 percent), Uruguay (1.8 percent), Brazil (1.75 percent), Chile (1.73 percent), the Netherlands (1.5 percent) and Ireland (1.5 percent).

Australia Cocaine is the second-most-popular illegal recreational drug in Australia (behind cannabis). Overall use has been on the rise since the mid-1990s, but rates and attitudes vary by state.

Europe

Cocaine use in the general population is highest (from 4.2 to 5.5 percent) in Denmark, Norway, Ireland, and the Netherlands, in that order.

South America South America is the world's third-largest market for cocaine, with approximately 1,981,000 users in 2004–2005. Use by people aged 15–64 was 0.7 percent, on a par with Europe but lower than North America's 2.3 percent. Use rates in the main coca-producing countries are at or above the regional average, indicating a connection between illicit crop cultivation, cocaine production, and local abuse. In Bolivia (where use is well above the Latin American average), annual rates have mirrored domestic production trends. After increasing from 1990 to 1996, rates declined; they rose again from 2000 to 2005, reaching 1.6 percent for cocaine hydrochloride and 1.9 percent for cocaine base in 2005.

United States

Cocaine is the second-most-popular illegal recreational drug in the United States (behind cannabis), and the U.S. is the world's largest consumer of cocaine. Its users span a variety of ages, races, and professions. The drug became particularly popular during the 1970s and 1980s in discos such as Studio 54.

Use in sports

Cocaine is prohibited for use in competition by the World Anti-Doping Agency (WADA), which classifies it as an S6 stimulant and a "substance of abuse" on its International Standard Prohibited List. Athletes who test positive for cocaine in competition may face disciplinary measures, although special consideration may be given if use occurred out of competition and was unrelated to performance.

Harm reduction

Experts recommend that anyone using stimulants such as cocaine or MDMA, and those around them, carry naloxone due to the growing risk of opioid contamination of the drug supply. Having naloxone available can help prevent fatal overdoses, even when opioids are not intentionally used. Nasal-spray formulations of naloxone are recommended because they are legal in many regions, easy to carry, and can be administered by anyone. The World Health Organization (WHO) includes naloxone on their List of Essential Medicines, and recommends its use for reversing opioid overdoses. In the United States, nasal naloxone is available without a prescription.

Harm reduction for cocaine use focuses on health risks associated with cocaine injection and smoking crack cocaine. It includes providing clean needles and crack-cocaine paraphernalia, promoting safer consumption practices, and offering drug-checking services to detect dangerous contaminants such as fentanyl. These strategies aim to minimize overdose risk and disease transmission, supporting user health and access to treatment.

Reagent testing Reagent testing kits are widely used to identify the presence of cocaine and its common adulterants. The Scott reagent is designed as a test for cocaine. The Morris reagent, derived from the Scott reagent, is also used to test for cocaine. The Liebermann and Mandelin reagents are commonly used to test for cocaine and levamisole, a cutting agent frequently found in street cocaine.

Each reagent provides different color indications for various substances. Since adulteration of cocaine with levamisole is widespread, the color reactions produced by these reagents often reflect the presence of both substances. The resulting mixed color can complicate interpretation, making further analysis or additional testing necessary to clarify the sample's composition.

DanceSafe recommends starting with the Morris reagent to identify cocaine; a bright-blue color indicates the presence of cocaine. No color change or light pink is normal with the Marquis reagent; orange may indicate amphetamines, and a test strip may be needed. With the Liebermann reagent on a fresh sample, yellow means pure cocaine; rusty red suggests levamisole or lidocaine.

Illicit supply chain According to a 2006 United Nations Office on Drugs and Crime report, 99 percent of global illicit cocaine was sourced from coca plantations in the Andesprimarily in Colombia, Peru, and Bolivia. While most coca cultivation is concentrated in South America, it is expanding into the Central American countries of Honduras, Guatemala, and Belize.

The global cocaine trade operates through an illicit supply chain shaped by geography and economics. Production begins in Latin America, where coca plants are cultivated and processed through several chemical stages: first into a crude extract known as cocaine paste, then into coca base, and finally refined into cocaine hydrochloride. Cocaine is occasionally adulterated with levamisole before shipment, increasing bulk and maximizing profits for traffickers. The drug is then trafficked, often across international borders, with a variety of smuggling routes and methods.

Although most cocaine paste and base are further processed in the source countries, some traffickers smuggle cocaine hydrochloride or cocaine paste by chemically concealing it in materials (such as plastics and liquids) which make detection difficult; one example is black cocaine. When the cocaine reaches its destination hub, it is transported to laboratories for extraction and refinement into cocaine hydrochloride or converted if the shipment arrives as cocaine paste. Several such facilities are detected in Europe each year.

After reaching the destination hub and being refined (if needed), cocaine hydrochloride is typically distributed in bulk to wholesale markets in consumer countries. After reaching these markets, it is broken down into smaller quantities for local markets. Cocaine is frequently adulterated, most commonly with the toxic stimulant levamisole, to increase profits; counterfeit cocaine, substances sold as cocaine but containing little or no actual cocaine, is also sometimes distributed.

Organization The cocaine trade has been dominated since the 1980s by centralized, hierarchical drug cartels such as Medellín and Cali, their successors, and early FARC factions. This model fragmented into a diverse network of global trafficking links by the early 2000s, allowing South American cocaine production to supply markets in Europe, Africa, Asia, and Oceania through a number of routes. According to the 2025 World Drug Report, violence linked to the cocaine trade continues to affect Latin America and the Caribbean and is expanding into Western Europe, Asia, and Africa as transnational organized crime groups compete globally.

Research in 2025 indicates that the global cocaine trade is shifting from violent, hierarchical cartels to professional, decentralized networks focused on logistics and cross-border collaboration. Violence is used more strategically and locally, rather than as the primary means of control.

Production

Colombia was the world's largest cocaine producer in 2019, with production more than tripling since 2013. Three-quarters of the world's annual yield of cocaine has been produced in Colombia from cocaine base imported from Peru (primarily the Huallaga Valley) and Bolivia and from locally-grown coca. There was a 28-percent increase in the number of potentially-harvestable 2019 coca plants in Colombia over 1998. This, combined with crop reductions in Bolivia and Peru, made Colombia the nation with the largest area of coca under cultivation after the mid-1990s. Coca grown for traditional purposes by indigenous communities, permitted by Colombian law, is a small fragment of total coca production; most is used for the illegal drug trade.

+ Estimated Andean region coca cultivation and potential pure cocaine production 20002001200220032004 Net cultivation km2 (sq mi) Potential pure cocaine production (tonnes)770925830680645